BMI1 and breast cancer: Among these miRNAs, miR-200c was found to inhibit BMI1 polycomb ring finger oncogene (BMI1), a regulator of stem cell self-renewal, and led to inhibition of clonal expansion of breast cancer cells in vitro, and strongly suppressed the tumor formation driven by BCSCs in vivo [64].